Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)

EJ Molloy, M El-Dib, J Soul, S Juul, AJ Gunn… - Pediatric …, 2024 - nature.com
The survival of preterm infants has steadily improved thanks to advances in perinatal and
neonatal intensive clinical care. The focus is now on finding ways to improve morbidities …

The proportions of term or late preterm births after exposure to early antenatal corticosteroids, and outcomes: systematic review and meta-analysis of 1.6 million infants

K Ninan, A Gojic, Y Wang, EV Asztalos, M Beltempo… - bmj, 2023 - bmj.com
Objective To systematically review the proportions of infants with early exposure to antenatal
corticosteroids but born at term or late preterm, and short term and long term outcomes …

Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind …

T Schmitz, M Doret-Dion, L Sentilhes, O Parant… - The Lancet, 2022 - thelancet.com
Background Antenatal betamethasone is recommended before preterm delivery to
accelerate fetal lung maturation. However, reports of growth and neurodevelopmental dose …

Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study

TC Yao, SM Chang, CS Wu, YF Tsai, KH Sheen… - bmj, 2023 - bmj.com
Objective To investigate the associations between exposure to antenatal corticosteroids and
serious infection in children during the first three, six, and 12 months of life. Design …

Consortium for the Study of Pregnancy Treatments (Co-OPT): An international birth cohort to study the effects of antenatal corticosteroids

EM Frier, C Lin, RM Reynolds, K Allegaert, JV Been… - PloS one, 2023 - journals.plos.org
Background Antenatal corticosteroids (ACS) are widely prescribed to improve outcomes
following preterm birth. Significant knowledge gaps surround their safety, long-term effects …

Antenatal steroids: benefits, risks, and new insights

EL Fee, SJ Stock, MW Kemp - Journal of endocrinology, 2023 - joe.bioscientifica.com
Being born before 37 weeks' gestation, or preterm birth, is a leading cause of early
childhood death and life-long disability. Antenatal steroids (ANS) are recommended for …

Prediction of preterm birth in women with fetal growth restriction–Is the weekly change in sFlt‐1/PlGF ratio or PlGF levels useful?

J Hong, K Crawford, E Cavanagh… - Acta Obstetricia et …, 2024 - Wiley Online Library
Introduction To assess the rate of change in soluble fms‐like tyrosine kinase‐1/placental
growth factor (sFlt‐1/PlGF) ratio and PlGF levels per week compared to a single sFlt‐1/PlGF …

Technical Update No. 438: Antenatal Corticosteroids at Late Preterm Gestation

J Liauw, H Foggin, P Socha, J Crane, KS Joseph… - Journal of Obstetrics and …, 2023 - Elsevier
Objective To update recommendations for administration of antenatal corticosteroids in the
late preterm period. Target Population Pregnant individuals at risk of preterm birth from 34 0 …

[HTML][HTML] Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)

EJ Molloy, M El-Dib, J Soul, S Juul, AJ Gunn… - Pediatric …, 2024 - ncbi.nlm.nih.gov
The survival of preterm infants has steadily improved thanks to advances in perinatal and
neonatal intensive clinical care. The focus is now on finding ways to improve morbidities …

Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks

AH Jobe, RL Goldenberg, MW Kemp - American Journal of Obstetrics and …, 2024 - Elsevier
Antenatal steroid therapy is increasingly central to the obstetrical management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …